Novel biomarkers in acute coronary syndromes: New molecules, new concepts, but what about new treatment strategies?

Journal of the American College of Cardiology

Volumn 63, Issue 16, 2014, Pages 1654-1656

  Filippatos, Gerasimos ^a   Farmakis, Dimitrios ^a   Parissis, John ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

acute coronary syndrome(s); biomarkers; copeptin; MR proADM; troponin

Indexed keywords

ADRENOMEDULLIN; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; COPEPTIN; MYELOPEROXIDASE; NATRIURETIC FACTOR; PREGNANCY ASSOCIATED PLASMA PROTEIN A; TROPONIN I; GROWTH DIFFERENTIATION FACTOR 15; PRO ATRIAL NATRIURETIC PEPTIDE; PROADRENOMEDULLIN; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; CARDIOVASCULAR MORTALITY; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; HEART FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; NOTE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN SECRETION; RISK FACTOR; UNSTABLE ANGINA PECTORIS; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; HEART PROTECTION; HEART STRESS; PREDICTIVE VALUE; PROTEIN EXPRESSION; RISK ASSESSMENT;

ACUTE CORONARY SYNDROME(S); BIOMARKERS; COPEPTIN; MR-PROADM; TROPONIN;

ACETANILIDES; ACUTE CORONARY SYNDROME; BIOLOGICAL MARKERS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; PIPERAZINES; THROMBOLYTIC THERAPY;

EID: 84899030319     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.11.055     Document Type: Editorial

References (14)

1. T. Reichlin, W. Hochholzer, and S. Bassetti et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays N Engl J Med 361 2009 858 867
2. A. Maisel, C. Mueller, and S.X. Neath et al. Copeptin helps in the early detection of patients with acute myocardial infarction: primary results of the CHOPIN trial (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction) J Am Coll Cardiol 62 2013 150 160
3. R.G. O'Malley, M.P. Bonaca, and B.M. Scirica et al. Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36) J Am Coll Cardiol 63 2014 1644 1653
4. O.S. Dhillon, S.Q. Khan, and H.K. Narayan et al. Prognostic value of mid-regional pro-adrenomedullin levels taken on admission and discharge in non-ST-elevation myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) II study J Am Coll Cardiol 56 2010 125 133
5. M. Sánchez, P. Llorens, P. Herrero, F.J. Martín-Sanchez, P. Piñera, O. Miró on behalf of COPEP Study Investigators The utility of copeptin in the emergency department as a predictor of adverse outcomes in non-ST-elevation acute coronary syndrome: the COPED-PAO study Emerg Med J 31 2014 286 291
6. S. Tzikas, T. Keller, and F.M. Ojeda et al. MR-proANP and MR-proADM for risk stratification of patients with acute chest pain Heart 99 2013 388 395
7. C. Widera, M.J. Pencina, and A. Meisner et al. Adjustment of the GRACE score by growth differentiation factor 15 enables a more accurate appreciation of risk in non-ST-elevation acute coronary syndrome Eur Heart J 33 2012 1095 1104
8. T. Omland, A. Aakvaag, and V.V. Bonarjee et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide Circulation 93 1996 1963 1969
9. D. Farmakis, G. Filippatos, and M. Tubaro et al. Natriuretic peptides in acute coronary syndromes: prognostic value and clinical implications Congest Heart Fail 14 Suppl 1 2008 25 29
10. H. Möllmann, H.M. Nef, and S. Kostin et al. Ischemia triggers BNP expression in the human myocardium independent from mechanical stress Int J Cardiol 143 2010 289 297
11. B.M. Scirica, D.A. Morrow, and C. Bode et al. Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 trial Eur Heart J 31 2010 1993 2005
12. I. Squire, P. Quinn, and H. Narayan et al. Identification of potential outcome benefit from ACE inhibition after acute coronary syndrome: a biomarker approach using N-terminal proBNP Heart 96 2010 831 837
13. W. Hochholzer, D.A. Morrow, and R.P. Giugliano Novel biomarkers in cardiovascular disease: update 2010 Am Heart J 160 2010 583 594
14. D. Farmakis, I. Andreadou, and A. Aessopos High-sensitivity troponin assays: ready for prime-time use as surrogates of subclinical myocardial injury? J Am Coll Cardiol 60 2012 166